Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vaccinating the Vulnerable Heart: RSV Prevention in Atrial Fibrillation.

European journal of preventive cardiology·2026

Same author

Deleterious impact of obstructive sleep apnea on autonomic nervous system control during rapid-eye-movement sleep in adult type 1 diabetes.

Physiological reports·2026

Same author

A simplified geometric CMR method for reproducible quantification of left ventricular thrombus volume : Left Ventricular thrombus: a standardized measurement method.

The international journal of cardiovascular imaging·2026

Same author

Impact of the MonCœur smartphone application on self-care and quality of life in heart failure: The APPLIMONCOEUR randomized trial.

Archives of cardiovascular diseases·2026

Same author

Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.

PloS one·2026

Same author

Relevance of left ventricular ejection fraction in the stratification of patients with heart failure: A nationwide picture.

Archives of cardiovascular diseases·2026

Same journal

Editorial introduction.

Current opinion in lipidology·2026

Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026

Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026

Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026

Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026

Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 24, 2026

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury

Published on: October 3, 2017

Is hypertriglyceridemia atherogenic?

Fabien Huet^1,2, Camille Roubille^2,3, François Roubille^1,2

¹Department of Cardiology, Montpellier University Hospital, Montpellier.

Current Opinion in Lipidology

|May 31, 2019

Summary

This summary is machine-generated.

Icosapent ethyl significantly reduces cardiovascular events and death, challenging the view of triglycerides as bystanders. This highlights the role of triglyceride-rich lipoproteins in cardiovascular disease and suggests new therapeutic avenues beyond LDL reduction.

More Related Videos

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Published on: August 25, 2020

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Related Experiment Videos

Last Updated: Jan 24, 2026

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury

Published on: October 3, 2017

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Published on: August 25, 2020

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Area of Science:

Cardiology
Metabolic Disorders
Lipid Metabolism

Background:

Hypertriglyceridemia is linked to metabolic disorders like diabetes, alcohol intake, and obesity, with genetic factors in severe cases.
Triglyceride-rich lipoproteins are increasingly implicated in cardiovascular disease (CVD) pathophysiology, contrary to previous beliefs.
Low-density lipoproteins (LDLs) have historically dominated atherosclerotic CVD management.

Purpose of the Study:

To review the role of triglyceride-rich lipoproteins in cardiovascular disease.
To discuss the findings of the REDUCE-IT trial regarding icosapent ethyl.
To explore the potential mechanisms of action for omega-3 fatty acids in CVD risk reduction.

Main Methods:

Review of recent biological, epidemiological, and clinical trial data.
Analysis of the REDUCE-IT trial outcomes.
Exploration of pleiotropic effects of omega-3 fatty acids.

Main Results:

The REDUCE-IT trial demonstrated that icosapent ethyl reduces major cardiovascular events and related mortality.
Omega-3 fatty acids, specifically icosapent ethyl, effectively reduced residual cardiovascular risk beyond statin therapy.
The cardiovascular benefits of icosapent ethyl appear independent of LDL cholesterol or triglyceride reduction, suggesting pleiotropic effects.

Conclusions:

Triglyceride-rich lipoproteins may be causal factors in atherosclerotic cardiovascular disease, necessitating their consideration in patient management.
Icosapent ethyl's efficacy suggests novel therapeutic pathways targeting inflammation, platelet adhesion, and plaque instability.
Further research is warranted to fully elucidate the mechanisms of omega-3 fatty acids and develop targeted therapies for cardiovascular risk reduction.